MDLN

Investor Moves

Investor	Portfolio Value	Portfolio Change	Position Change	Avg Buy Price	Current Price
Andreas HalvorsenViking Global $509M11.4M shares AddQ1 2026 $217M $44.50 $35.84

Insider Trades

Actor	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
BCP 8 Holdings Mozart Manager L.L.C.10 Percent Owner --1.5M shares OtherMay 21, 2026 Disclosure amount unavailable1.5M shares -- $35.84
BCP 8 Holdings Mozart Manager L.L.C.10 Percent Owner --9.9M shares OtherMay 21, 2026 Disclosure amount unavailable9.9M shares -- $35.84
BCP 8 Holdings Mozart Manager L.L.C.10 Percent Owner --1.5M shares Grant / ExerciseMay 21, 2026 Disclosure amount unavailable1.5M shares -- $35.84
BCP 8 Holdings Mozart Manager L.L.C.10 Percent Owner --9.9M shares Grant / ExerciseMay 21, 2026 Disclosure amount unavailable9.9M shares -- $35.84

News

seekingalpha.comMedline Inc. (MDLN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcriptseekingalpha.comJun 9

businesswire.comSecurities Fraud Investigation Into Medline Industries, Inc. (MDLN) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firmbusinesswire.comJun 9

gurufocus.comMedline Industries, Inc. (MDLN) Shareholders Who Lost Money -- Contact Law Offices of Howard G. Smith About Securities Fraud Investigationgurufocus.comJun 9

gurufocus.comSecurities Fraud Investigation Into Medline Industries, Inc. (MDLN) Announced -- Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruzgurufocus.comJun 8

businesswire.comSecurities Fraud Investigation Into Medline Industries, Inc. (MDLN) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruzbusinesswire.comJun 8

Trade MDLN

About Medline Inc.

Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.

CEO: James Boyle
IPO Date: Dec 17, 2025

Market Data

Market data refresh is queued when this stock page is viewed.

Valuation

Valuation snapshot is not available yet.

Financials

Financial statement snapshot is not available yet.

Events

EarningsSep 2

EPS est. 0.3241